Anti-CD20 antibody therapy and risk of infection in patients with demyelinating diseases
N. Oksbjerg(Copenhagen University Hospital), Finn Sellebjerg(Danish Multiple Sclerosis Center), Melinda Magyari(University of Copenhagen), Morten Blinkenberg(Copenhagen University Hospital), Susanne Dam Nielsen(University of Copenhagen)
Cited by 67
Related Papers
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Worldwide Incidence and Prevalence of Neuromyelitis Optica
|Neurology|2020|303
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
|CNS Drugs|2014|293
Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis
|JAMA Neurology|2021|237
Apparent changes in the epidemiology and severity of multiple sclerosis
|Nature Reviews Neurology|2021|209